SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007820
Filing Date
2023-11-09
Accepted
2023-11-09 17:00:42
Documents
47
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT xenetic_i10q-093023.htm   iXBRL 10-Q 589036
2 CERTIFICATION xenetic_ex3101.htm EX-31.1 9973
3 CERTIFICATION xenetic_ex3102.htm EX-31.2 10234
4 CERTIFICATION xenetic_ex3201.htm EX-32.1 4553
  Complete submission text file 0001683168-23-007820.txt   2636519

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE xbio-20230930.xsd EX-101.SCH 23927
6 XBRL CALCULATION FILE xbio-20230930_cal.xml EX-101.CAL 28452
7 XBRL DEFINITION FILE xbio-20230930_def.xml EX-101.DEF 111734
8 XBRL LABEL FILE xbio-20230930_lab.xml EX-101.LAB 171502
9 XBRL PRESENTATION FILE xbio-20230930_pre.xml EX-101.PRE 143320
41 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_i10q-093023_htm.xml XML 268424
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 231393551
SIC: 2834 Pharmaceutical Preparations